Achilles tendinitis is the inflammation and irritation to the Achilles tendon, and occasionally the Achilles tendon sheath
Its bacteriostatic agent helps prevent contamination, which is essential for ensuring patient safety during repeated use
A double-blind, placebo-controlled, multicenter study of 90 patients found that intramuscular ALC (500 mg twice daily for 14 days followed by oral ALC 1,000 mg twice daily for 42 days) produced significantly greater reduction in pain compared with placebo in the efficacy-evaluable population (P=0.022).[4] An open cohort study of 21 HIV-positive patients with established ATN treated with oral ALC 1,500 mg twice daily for up to 33 months demonstrated remarkable nerve regeneration: mean immunostaining area for small sensory fibers increased 100% in epidermis and 133% in dermis after 6 months, with neuropathic grade improving in 76% of patients.[5] However, a subsequent open-label study found that while ALC therapy coincided with improvements in subjective measures of pain, changes were not observed in objective measures of intra-epidermal nerve fiber density or mitochondrial DNA levels.[6] Context with Other Treatments: Second-line or adjunctive therapy for ATN
If at any time you wish your personal information to be removed from the American Regent database, please submit a message request to [email protected]
Its a level of customization and precision that goes beyond standard injections and reflects an advanced blend you wont find at any other clinic
Data from the Phase III clinical trial showed that supplementation selenium in a concentration of 200400 g for 35 years did not lead to any adverse outcomes such as prostate cancer mortality or PSA velocity in patients with a high risk of prostate cancer [75]
